Cord Blood America Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,975.00
4,331.10
5,227.80
-
-
9.10
Cost of Goods Sold (COGS) incl. D&A
2,791.40
1,847.70
1,864.50
5.30
5.40
9.10
Gross Income
3,183.50
2,483.40
3,363.30
5.30
5.40
9.10
SG&A Expense
4,329.80
2,652.30
3,005.10
2,126.50
1,694.00
3,867.50
EBIT
1,146.30
169.00
-
-
1,699.40
3,876.60
Unusual Expense
189.60
63.10
951.70
479.70
109.70
-
Non Operating Income/Expense
-
331.00
27.40
34.40
27.50
104.70
Interest Expense
1,704.90
416.80
899.40
305.60
54.50
-
Pretax Income
3,040.70
191.60
437.90
1,923.30
1,616.60
3,771.90
Income Tax
61.80
-
-
-
-
714.60
Consolidated Net Income
2,978.90
191.60
437.90
1,923.30
1,616.60
3,057.20
Net Income
2,466.70
191.60
437.90
1,923.30
1,616.60
3,057.20
Net Income After Extraordinaries
2,466.70
623.20
437.90
3,948.80
3,640.50
19,287.90
Net Income Available to Common
2,466.70
529.80
437.90
102.20
407.40
2,800.10
EPS (Basic)
0.00
0.00
0.00
0.00
0.00
0.01
Basic Shares Outstanding
747,129.40
890,000.00
1,272,066.10
1,272,066.10
1,272,066.10
1,272,066.10
EPS (Diluted)
0.00
0.00
0.00
0.00
0.00
0.01
Diluted Shares Outstanding
747,129.40
895,106.80
1,272,066.10
1,272,066.10
1,272,066.10
1,272,066.10
EBITDA
358.90
305.60
758.10
2,126.50
1,694.00
3,867.50
Minority Interest Expense
512.10
-
-
-
-
-
About Cord Blood America
View Profile
